ID: MRFR/Pharma/7918-HCR | August, 2022 | Region : Global
Table of Contents
1. EXECUTIVE SUMMARY
1.1. Market Attractiveness Analysis
1.1.1. Global AI in Drug Discovery Market, by Product Type
1.1.2. Global AI in Drug Discovery Market, by Molecule Type
1.1.3. Global AI in Drug Discovery Market, by Technology
1.1.4. Global AI in Drug Discovery Market, by Indication
1.1.5. Global AI in Drug Discovery Market, by Application
1.1.6. Global AI in Drug Discovery Market, by End User
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.2.1. Secondary Research
3.2.2. Primary Research
3.2.2.1. Breakdown of Primary Respondents
3.2.3. Forecasting Techniques
3.3. Research Methodology for Market Size Estimation
3.3.1. Bottom-Up Approach
3.3.2. Top-Down Approach
3.4. Data Triangulation
3.5. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porterβs Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
5.2.1. R&D and Designing
5.2.2. Manufacturing
5.2.3. Distribution & Sales
5.2.4. Post Sales Services
6. GLOBAL AI IN DRUG DISCOVERY MARKET, BY PRODUCT TYPE
6.1. Overview
6.2. Software
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
6.3. Services
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
7. GLOBAL AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE
7.1. Overview
7.2. Large Molecule
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
7.3. Small Molecule
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
8. GLOBAL AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY
8.1. Overview
8.2. Machine Learning
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
8.3. Deep Learning
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
8.4 Others
9. GLOBAL AI IN DRUG DISCOVERY MARKET, BY INDICATION
9.1. Overview
9.2. Immuno-Oncology
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
9.3. Neurodegenerative Diseases
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
9.4. Cardiovascular Diseases
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
9.5. Metabolic Diseases
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
9.6. Others
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
10. GLOBAL AI IN DRUG DISCOVERY MARKET, BY APPLICATION
10.1. Overview
10.2. Target Identification
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
10.3. Candidate Screening
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
10.4. De novo Drug Designing
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
10.5. Drug Optimization and Repurposing
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
10.6. Preclinical Testing
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
11. GLOBAL AI IN DRUG DISCOVERY MARKET, BY END USER
11.1. Overview
11.2. Pharmaceutical & Biotechnology Companies
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
11.3. Contract Research Organizations
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
11.4. Research Centers and Academic & Government Institutes
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
12. GLOBAL AI IN DRUG DISCOVERY MARKET, BY REGION
12.1. Overview
12.2. Americas
12.2.1. North America
12.2.1.1. US
12.2.1.2. Canada
12.2.2. Latin America
12.3. Europe
12.3.1. Western Europe
12.3.1.1. Germany
12.3.1.2. France
12.3.1.3. UK
12.3.1.4. Italy
12.3.1.5. Spain
12.3.1.6. Rest of Western Europe
12.3.2. Eastern Europe
12.4. Asia-Pacific
12.4.1. Japan
12.4.2. China
12.4.3. India
12.4.4. Australia
12.4.5. South Korea
12.4.6. Rest of Asia-Pacific
12.5. Middle East & Africa
12.5.1. Middle East
12.5.2. Africa
13. COMPANY LANDSCAPE
13.1. Overview
13.2. Competitor Dashboard
13.2.1. Company Share Analysis
13.2.2. Major Growth Strategy in the global AI in Drug Discovery Market
13.3. Competitive Benchmarking
13.3.1. Leading Players in terms of Number of Developments in the Global AI in Drug Discovery Market
13.3.2. Key Developments & Growth Strategies
13.3.3. Major Players Financial Matrix & Market Ratio
14. COMPANY PROFILE
14.1. Microsoft Corporation
14.1.1. Company Overview
14.1.2. Products/Services Offered
14.1.3. Financial Overview
14.1.4. Key Developments
14.1.5. SWOT Analysis
14.1.6. Key Strategies
14.2. NVIDIA Corporation
14.3. IBM Corporation
14.4. Google (A Subsidiary of Alphabet Inc.)
14.5. Atomwise, Inc.
14.6. Deep Genomics
14.7. Cloud Pharmaceuticals, Inc.
14.8. Insilico Medicine
14.9. Benevolentai
14.10. Exscientia
14.11. Cyclica
14.12. Bioage
14.13. Numerate
14.14. Numedii, Inc.
14.15. Envisagenics
14.16. Twoxar, Incorporated
14.17. Owkin, Inc.
14.18. Xtalpi, Inc.
14.19. Verge Genomics
14.20. Berg LLC
14.21. Others
15. APPENDIX
15.1. References
15.2. Related Reports
NOTE:
This table of content is tentative and subject to change as the research progresses.
ο‘ In section 14, the top ten companies will be profiled. Each company will be profiled based on the Market Overview, Financials, Product Portfolio, Business Strategies, and Recent Developments parameters.
ο‘ Please note: The financial details of the company cannot be provided if the information is not available in the public domain and or from reliable sources.
$7,918.93 Million
41.7%
North America
2022-2030